Correlation Between Neximmune and Orgenesis
Can any of the company-specific risk be diversified away by investing in both Neximmune and Orgenesis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neximmune and Orgenesis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neximmune and Orgenesis, you can compare the effects of market volatilities on Neximmune and Orgenesis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neximmune with a short position of Orgenesis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neximmune and Orgenesis.
Diversification Opportunities for Neximmune and Orgenesis
Poor diversification
The 3 months correlation between Neximmune and Orgenesis is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Neximmune and Orgenesis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orgenesis and Neximmune is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neximmune are associated (or correlated) with Orgenesis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orgenesis has no effect on the direction of Neximmune i.e., Neximmune and Orgenesis go up and down completely randomly.
Pair Corralation between Neximmune and Orgenesis
Given the investment horizon of 90 days Neximmune is expected to generate 1.9 times more return on investment than Orgenesis. However, Neximmune is 1.9 times more volatile than Orgenesis. It trades about 0.03 of its potential returns per unit of risk. Orgenesis is currently generating about -0.13 per unit of risk. If you would invest 280.00 in Neximmune on September 22, 2024 and sell it today you would lose (37.00) from holding Neximmune or give up 13.21% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 19.77% |
Values | Daily Returns |
Neximmune vs. Orgenesis
Performance |
Timeline |
Neximmune |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Orgenesis |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Neximmune and Orgenesis Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Neximmune and Orgenesis
The main advantage of trading using opposite Neximmune and Orgenesis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neximmune position performs unexpectedly, Orgenesis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orgenesis will offset losses from the drop in Orgenesis' long position.Neximmune vs. ZyVersa Therapeutics | Neximmune vs. Palisade Bio | Neximmune vs. Unicycive Therapeutics | Neximmune vs. Immix Biopharma |
Orgenesis vs. Tff Pharmaceuticals | Orgenesis vs. Quoin Pharmaceuticals Ltd | Orgenesis vs. Aerovate Therapeutics | Orgenesis vs. Adagene |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |